Not your institution?

Works by Greil, Richard

Results: 244
    1
    2
    3
    4
    5
    6

    Polatuzumab Vedotin plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (pola-R-CHP) Versus Rituximab, Cyclophosphamide, Doxorubicin, Vincristine and Prednisone (R-CHOP) Therapy in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma: Results from the Phase III POLARIX Study

    Published in:
    Acta Haematologica Polonica, 2022, v. 53, n. A, p. 56
    By:
    • Jurczak, Wojciech;
    • Tilly, Hervé;
    • Morschhauser, Franck;
    • Sehn, Laurie H.;
    • Friedberg, Jonathan W.;
    • Trněný, Marek;
    • Sharman, Jeff P.;
    • Herbaux, Charles;
    • Burke, John M.;
    • Matasar, Matthew;
    • Rai, Shinya;
    • Koji Izutsu;
    • Mehta-Shah, Neha;
    • Oberic, Lucie;
    • Chauchet, Adrien;
    • Yuqin Song;
    • Greil, Richard;
    • Mykhalska, Larysa;
    • Bergua Burgués, Juan Miguel;
    • Cheung, Matthew C.
    Publication type:
    Article
    7

    SEQUOIA: results of a phase 3 randomized study of Zanubrutinib versus Bendamustine + Rituximab (BR) in patients with treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

    Published in:
    Acta Haematologica Polonica, 2022, v. 53, n. A, p. 32
    By:
    • Robak, Tadeusz;
    • Giannopoulos, Krzysztof;
    • Jurczak, Wojciech;
    • Šimkovič, Martin;
    • Shadman, Mazyar;
    • Österborg, Anders;
    • Laurenti, Luca;
    • Walker, Patricia;
    • Opat, Stephen;
    • Chan, Henry;
    • Ciepluch, Hanna;
    • Greil, Richard;
    • Tani, Monica;
    • Trněný, Marek;
    • Brander, Danielle M.;
    • Flinn, Ian W.;
    • Grosicki, Sebastian;
    • Verner, Emma;
    • Kahl, Brad S.;
    • Ghia, Paolo
    Publication type:
    Article
    8

    Synergistic action of protein kinase C θ and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.

    Published in:
    European Journal of Immunology, 1999, v. 29, n. 11, p. 3549, doi. 10.1002/(SICI)1521-4141(199911)29:11<3549::AID-IMMU3549>3.0.CO;2-Q
    By:
    • Villunger, Andreas;
    • Ghaffari-Tabrizi, Nassim;
    • Tinhofer, Inge;
    • Krumböck, Nina;
    • Bauer, Birgit;
    • Schneider, Thomas;
    • Kasibhatla, Shailaja;
    • Greil, Richard;
    • Baier-Bitterlich, Gabriele;
    • Überall, Florian;
    • Green, Douglas R.;
    • Baier, Gottfried
    Publication type:
    Article
    9
    10
    11
    12
    13

    Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine—A Prospective Cohort Study by the AGMT.

    Published in:
    Cancers, 2023, v. 15, n. 5, p. 1388, doi. 10.3390/cancers15051388
    By:
    • Pleyer, Lisa;
    • Heibl, Sonja;
    • Tinchon, Christoph;
    • Vallet, Sonia;
    • Schreder, Martin;
    • Melchardt, Thomas;
    • Stute, Norbert;
    • Föhrenbach Quiroz, Kim Tamara;
    • Leisch, Michael;
    • Egle, Alexander;
    • Scagnetti, Lukas;
    • Wolf, Dominik;
    • Beswick, Richard;
    • Drost, Manuel;
    • Larcher-Senn, Julian;
    • Grochtdreis, Thomas;
    • Vaisband, Marc;
    • Hasenauer, Jan;
    • Zaborsky, Nadja;
    • Greil, Richard
    Publication type:
    Article
    14

    The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells.

    Published in:
    Cancers, 2023, v. 15, n. 4, p. 1039, doi. 10.3390/cancers15041039
    By:
    • Urwanisch, Laura;
    • Unger, Michael Stefan;
    • Sieberer, Helene;
    • Dang, Hieu-Hoa;
    • Neuper, Theresa;
    • Regl, Christof;
    • Vetter, Julia;
    • Schaller, Susanne;
    • Winkler, Stephan M.;
    • Kerschbamer, Emanuela;
    • Weichenberger, Christian X.;
    • Krenn, Peter W.;
    • Luciano, Michela;
    • Pleyer, Lisa;
    • Greil, Richard;
    • Huber, Christian G.;
    • Aberger, Fritz;
    • Horejs-Hoeck, Jutta
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity.

    Published in:
    Molecular Oncology, 2020, v. 14, n. 9, p. 1930, doi. 10.1002/1878-0261.12758
    By:
    • Grund‐Gröschke, Sandra;
    • Ortner, Daniela;
    • Szenes‐Nagy, Antal B.;
    • Zaborsky, Nadja;
    • Weiss, Richard;
    • Neureiter, Daniel;
    • Wipplinger, Martin;
    • Risch, Angela;
    • Hammerl, Peter;
    • Greil, Richard;
    • Sibilia, Maria;
    • Gratz, Iris K.;
    • Stoitzner, Patrizia;
    • Aberger, Fritz
    Publication type:
    Article
    22

    Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.

    Published in:
    2021
    By:
    • Bartsch, Rupert;
    • Singer, Christian F.;
    • Pfeiler, Georg;
    • Hubalek, Michael;
    • Stoeger, Herbert;
    • Pichler, Angelika;
    • Petru, Edgar;
    • Bjelic-Radisic, Vesna;
    • Greil, Richard;
    • Rudas, Margaretha;
    • Muy-Kheng, Tea Maria;
    • Wette, Viktor;
    • Petzer, Andreas L.;
    • Sevelda, Paul;
    • Egle, Daniel;
    • Dubsky, Peter C.;
    • Filipits, Martin;
    • Fitzal, Florian;
    • Exner, Ruth;
    • Jakesz, Raimund
    Publication type:
    journal article
    23
    24
    25

    A new trisaccharide derivative from Prenanthes purpurea.

    Published in:
    Journal of the Serbian Chemical Society, 2011, v. 76, n. 6, p. 841, doi. 10.2298/JSC101210072P
    By:
    • POSCH, MICHAELA;
    • JÖHRER, KARIN;
    • CICEK, SERHAT SEZAI;
    • GREIL, RICHARD;
    • ELLMERER, ERNST P.;
    • ZIDORN, CHRISTIAN
    Publication type:
    Article
    26
    27
    28
    29

    Aging restricts the ability of mesenchymal stem cells to promote the generation of oligodendrocytes during remyelination.

    Published in:
    Glia (0894-1491), 2019, v. 67, n. 8, p. 1510, doi. 10.1002/glia.23624
    By:
    • Rivera, Francisco J.;
    • Fuente, Alerie G.;
    • Zhao, Chao;
    • Silva, Maria E.;
    • Gonzalez, Ginez A.;
    • Wodnar, Roman;
    • Feichtner, Martina;
    • Lange, Simona;
    • Errea, Oihana;
    • Priglinger, Eleni;
    • O'Sullivan, Anna;
    • Romanelli, Pasquale;
    • Jadasz, Janusz J.;
    • Brachtl, Gabriele;
    • Greil, Richard;
    • Tempfer, Herbert;
    • Traweger, Andreas;
    • Bátiz, Luis F.;
    • Küry, Patrick;
    • Couillard‐Despres, Sebastien
    Publication type:
    Article
    30

    A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.

    Published in:
    2018
    By:
    • on behalf of the Austrian Breast and Colorectal Cancer Study Group (ABCSG);
    • Austrian Breast and Colorectal Cancer Study Group (ABCSG);
    • Piringer, Gudrun;
    • Burgstaller, Sonja;
    • Thaler, Josef;
    • Frantal, Sophie;
    • Gnant, Michael;
    • Fridrik, Michael;
    • Fridrik, Alfred;
    • Leiherer, Andreas;
    • Zabernigg, August;
    • Greil, Richard;
    • Eisterer, Wolfgang;
    • Tschmelitsch, Jörg;
    • Lang, Alois
    Publication type:
    journal article
    31
    32
    33
    34
    35

    Poly-ligand profiling differentiates trastuzumab-treated breast cancer patients according to their outcomes.

    Published in:
    Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03631-z
    By:
    • Domenyuk, Valeriy;
    • Gatalica, Zoran;
    • Santhanam, Radhika;
    • Xixi Wei;
    • Stark, Adam;
    • Kennedy, Patrick;
    • Toussaint, Brandon;
    • Levenberg, Symon;
    • Jie Wang;
    • Nianqing Xiao;
    • Greil, Richard;
    • Rinnerthaler, Gabriel;
    • Gampenrieder, Simon P.;
    • Heimberger, Amy B.;
    • Berry, Donald A.;
    • Barker, Anna;
    • Quackenbush, John;
    • Marshall, John L.;
    • Poste, George;
    • Vacirca, Jeffrey L.
    Publication type:
    Article
    36

    Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 14, p. 3440, doi. 10.1080/10428194.2021.1964020
    By:
    • Staber, Philipp Bernhard;
    • Jurczak, Wojciech;
    • Greil, Richard;
    • Vucinic, Vladan;
    • Middeke, Jan Moritz;
    • Montillo, Marco;
    • Munir, Talha;
    • Neumeister, Peter;
    • Schetelig, Johannes;
    • Stilgenbauer, Stephan;
    • Striebel, Frank;
    • Dirnberger-Hertweck, Maren;
    • Weirather, Johannes;
    • Brugger, Wolfram;
    • Kelemen, Peter;
    • Wendtner, Clemens-Martin;
    • Woyach, Jennifer Ann
    Publication type:
    Article
    37

    Real life experience with frontline azacitidine in a large series of older adults with acute myeloid leukemia stratified by MRC/LRF score: results from the expanded international E-ALMA series (E-ALMA+).

    Published in:
    Leukemia & Lymphoma, 2018, v. 59, n. 5, p. 1113, doi. 10.1080/10428194.2017.1365854
    By:
    • for the European ALMA + Investigators;
    • Falantes, José;
    • Itzykson, Raphael;
    • Fenaux, Pierre;
    • Pinto, Ricardo;
    • Bargay, Joan;
    • Burgstaller, Sonja;
    • Martínez, María Pilar;
    • Seegers, Valerie;
    • Gardin, Claude;
    • Cortesão, Emilia;
    • Foncillas, María Ángeles;
    • Montesinos, Pau;
    • Sanz, Miguel Angel;
    • Musto, Pellegrino;
    • Pleyer, Lisa;
    • Greil, Richard;
    • Thépot, Sylvain;
    • Almeida, António M.;
    • Maurillo, Luca
    Publication type:
    Article
    38
    39

    Low Beclin-1 expression predicts improved overall survival in patients treated with immunomodulatory drugs for multiple myeloma and identifies autophagy inhibition as a promising potentially druggable new therapeutic target: an analysis from The Austrian Myeloma Registry (AMR)

    Published in:
    Leukemia & Lymphoma, 2016, v. 57, n. 10, p. 2330, doi. 10.3109/10428194.2016.1144880
    By:
    • Willenbacher, Wolfgang;
    • Thangavadivel, Shanmugapriya;
    • Greil, Richard;
    • Willenbacher, Ella;
    • Weger, Roman;
    • Manzl, Claudia;
    • Jöhrer, Karin;
    • Brunner, Andrea
    Publication type:
    Article
    40
    41
    42
    43
    44

    Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042301
    By:
    • Rinnerthaler, Gabriel;
    • Gampenrieder, Simon Peter;
    • Petzer, Andreas;
    • Hubalek, Michael;
    • Petru, Edgar;
    • Sandholzer, Margit;
    • Andel, Johannes;
    • Balic, Marija;
    • Melchardt, Thomas;
    • Hauser-Kronberger, Cornelia;
    • Schmitt, Clemens A.;
    • Ulmer, Hanno;
    • Greil, Richard
    Publication type:
    Article
    45
    46

    The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: post hoc analysis of an Austrian multicenter, noninterventional study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835919900872
    By:
    • Riedl, Jakob Michael;
    • Posch, Florian;
    • Prager, Gerald;
    • Eisterer, Wolfgang;
    • Oehler, Leopold;
    • Sliwa, Thamer;
    • Wilthoner, Klaus;
    • Petzer, Andreas;
    • Pichler, Petra;
    • Hubmann, Eva;
    • Winder, Thomas;
    • Burgstaller, Sonja;
    • Korger, Markus;
    • Andel, Johannes;
    • Greil, Richard;
    • Neumann, Hans-Joerg;
    • Pecherstorfer, Martin;
    • Philipp-Abbrederis, Kathrin;
    • Djanani, Angela;
    • Gruenberger, Birgit
    Publication type:
    Article
    47

    Oncogenic MTOR Signaling Axis Compensates BTK Inhibition in a Chronic Lymphocytic Leukemia Patient with Richter Transformation: A Case Report and Review of the Literature.

    Published in:
    Acta Haematologica, 2024, v. 147, n. 5, p. 604, doi. 10.1159/000537791
    By:
    • Parigger, Thomas;
    • Drothler, Stephan;
    • Scherhäufl, Christian;
    • Gassner, Franz Josef;
    • Schubert, Maria;
    • Steiner, Markus;
    • Höpner, Jan Philip;
    • Hödlmoser, Alexandra;
    • Schultheis, Lena;
    • Bakar, Aryunni Abu;
    • Neureiter, Daniel;
    • Pleyer, Lisa;
    • Egle, Alexander;
    • Greil, Richard;
    • Geisberger, Roland;
    • Zaborsky, Nadja
    Publication type:
    Article
    48

    Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.

    Published in:
    Journal of Pathology, 2015, v. 236, n. 4, p. 445, doi. 10.1002/path.4539
    By:
    • Merkel, Olaf;
    • Hamacher, Frank;
    • Griessl, Robert;
    • Grabner, Lisa;
    • Schiefer, Ana‐Iris;
    • Prutsch, Nicole;
    • Baer, Constance;
    • Egger, Gerda;
    • Schlederer, Michaela;
    • Krenn, Peter William;
    • Hartmann, Tanja Nicole;
    • Simonitsch‐Klupp, Ingrid;
    • Plass, Christoph;
    • Staber, Philipp Bernhard;
    • Moriggl, Richard;
    • Turner, Suzanne D;
    • Greil, Richard;
    • Kenner, Lukas
    Publication type:
    Article
    49
    50